Evidence map›Paper›PMID 27793274›Full record

ArticleAnnals of epidemiology2016

Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation.

Alison L Van Dyke, Troy J Kemp, Amanda F Corbel, Bin Zhu, Yu-Tang Gao, Bing-Sheng Wang, Asif Rashid, Ming-Chang Shen, Allan Hildesheim, Ann W Hsing and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Annals of epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. The footprint of gut microbiota in gallbladder cancer: a mechanistic review.Frontiers in cellular and infection microbiology · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Association of circulating inflammation proteins and gallstone disease.Journal of gastroenterology and hepatology · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Alison L Van DykeInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD. Electronic address: alison.vandyke@nih.gov.
Troy J KempHPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
Amanda F CorbelInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD.
Bin ZhuBiostatistics Branch, DCEG, NCI, Bethesda, MD.
Yu-Tang GaoDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
Bing-Sheng WangDepartment of General Surgery, Zhongshan Hospital, School of Medicine, Fudan University, Shanghai, China.
Asif RashidDepartment of Pathology, MD Anderson Cancer Center, Houston, TX.
Ming-Chang ShenDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai, China; Department of Pathology, Cancer Hospital, Fudan University, Shanghai, China.
Allan HildesheimInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD.
Ann W HsingCenter for Innovative Global Health, Stanford Cancer Institute, Stanford University, Stanford, CA.
Ligia A PintoHPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
Jill KoshiolInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD.
National Cancer Institute · USFrederick National Laboratory for Cancer Research · USFudan University · CNFudan University Shanghai Cancer Center · CNShanghai Cancer Institute · CNStanford University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Etiology of Biliary Tract CancerZIACP010218 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI KOSHIOL, JILL · 2011 to 2025
$30.4M
Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

purposeWe examined inflammation as a mediator of associations between bacterial infection markers and gallbladder cancer (GBC).

methodsBacterial response proteins (lipopolysaccharide [LPS], soluble cluster of differentiation 14 [sCD14], and LPS-binding protein [LBP]) were measured in 40 GBC cases and 126 gallstone controls with data on 63 serum inflammation markers. The relationships of LPS, LBP, and sCD14 with GBC were examined by logistic regression, which also was used to evaluate whether these associations are influenced by systemic inflammation as measured by a combinatorial inflammation score.

resultsThe third versus the first tertiles of sCD14 and of LBP were associated with an increased GBC risk (odds ratio [95% confidence interval]: 5.41 [2.00-16.75] for sCD14, and 6.49 [2.24-23.79] for LBP). sCD14 and LBP were strongly associated with inflammation score (above vs. below the median), which itself was associated with a more than 21-fold increased risk of GBC for the third versus first tertiles. Associations between GBC and sCD14 and LBP were markedly attenuated when the inflammation score was included in the model. While LPS was not associated with GBC or inflammation, only 35% of cases and 22% of controls had detectable levels.

conclusionsThese findings suggest that these LPS-pathway proteins are associated with GBC via inflammation-related pathways.

Indexed as

Acute-Phase ProteinsAdultAge DistributionBiomarkers, TumorCarrier ProteinsCase-Control StudiesChinaCholecystitisDatabases, FactualFemaleGallbladder NeoplasmsHumansIncidenceLipopolysaccharide-Binding ProteinMaleMembrane GlycoproteinsAcute-Phase ProteinsBiomarkers, TumorCarrier ProteinsLipopolysaccharide-Binding ProteinMembrane GlycoproteinsGallbladder cancerInflammationLipopolysaccharide-pathwayMediation analysis

Identifiers

PMID27793274
PMCPMC5123694
OpenAlexW2516453000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.